\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesThe EIT has opened the call for a new EIT Knowledge and Innovation Community (EIT KIC) in the water, marine and maritime sectors and ecosystems. It will address global challenges including: water scarcity, droughts and floods as well as marine and freshwater degradation.
The main goal of this new organisation will be to strengthen the blue economy and Europe's competitiveness through innovation by bringing together top experts from the knowledge triangle (education, research and business).
All details and the application procedure can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Agro-Food, Environment
The Sustainable Blue Economy Partnership brings together 74 partner institutions from 32 countries and the European Commission under Horizon Europe. They have recently opened a new transnational access call to marine and maritime research infrastructures with several intermediary deadlines. The next cut-off is 20 October 2026 at 11:00 CEST. T... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
